Etiocholanolone Test

Most hormone testing tells you how much of an active hormone is in your blood right now. Etiocholanolone tells you something different. It is one of the final waste products your body produces after using and breaking down male-type hormones (androgens) like testosterone and DHEA. The level reflects how your body is processing those hormones, not how much active hormone you currently have.

This is a research-grade marker, not a routine clinical test. It is most useful when paired with its sibling metabolite androsterone to assess specific enzyme activity. A single reading does not tell you much in isolation, but the pattern across related steroid metabolites can reveal shifts in liver hormone processing, bone-related steroid signaling, and adrenal pathway activity that standard hormone panels miss.

What This Biomarker Actually Reflects

Etiocholanolone (5-beta-androstan-3-alpha-ol-17-one) is an inactive end-product, meaning it no longer acts on hormone receptors. Your liver is the main site where androgens like testosterone and DHEA are converted into etiocholanolone and its mirror-image cousin androsterone. The two differ only in their 3D shape at one carbon atom, but that small difference matters because it reflects which enzyme handled the breakdown.

Etiocholanolone is generated almost exclusively from the classic androgen breakdown pathway. Androsterone, on the other hand, can come from an alternative route. Looking at the ratio between the two gives clinicians a window into which enzymes are most active and whether your body is using a normal or alternative pathway to process these hormones.

The Androsterone Ratio

The androsterone-to-etiocholanolone ratio (often written as An/Et) is the most clinically informative use of this marker. A higher ratio suggests more activity from an enzyme called 5-alpha-reductase, which is the same enzyme blocked by drugs like finasteride. A lower ratio suggests the opposite balance. Shifts in this ratio have been documented in obesity with insulin resistance, polycystic ovary syndrome, congenital adrenal disease, and severe anorexia.

Liver Disease and Fibrosis

In nonalcoholic fatty liver disease (NAFLD), the sulfated form of etiocholanolone (etiocholanolone-S) tends to drop as liver scarring (fibrosis) gets worse. A study of 149 people with NAFLD (with separate comparison groups of healthy controls and primary biliary cirrhosis patients) found that the ratio of another metabolite (16-OH-DHEA-S) to etiocholanolone-S tracked closely with fibrosis stage. This change appears specific to NAFLD and was not seen the same way in another liver condition called primary biliary cirrhosis, suggesting it reflects something particular about how a fatty liver mishandles sex hormone metabolism.

What this means for you: if you have known fatty liver disease or risk factors for it (obesity, insulin resistance, metabolic syndrome), a falling trend in this marker over time, alongside rising liver enzymes, is a pattern worth investigating further with imaging or specialist evaluation.

Bone Density After Menopause

In postmenopausal women, higher serum etiocholanolone has been linked to better bone mineral density. Women with osteoporosis showed lower levels than those with normal bone density in an observational study. The same study also found that etiocholanolone levels correlated with specific gut bacteria (Bacteroides species) and with steroid hormone biosynthesis pathways, suggesting a gut-hormone-bone connection that researchers are still mapping out.

What this means for you: if you are postmenopausal and tracking bone health, this marker can add detail to a picture that already includes a DEXA scan and bone turnover markers. It is not a replacement for those tests.

Insulin Resistance and PCOS

In children and adolescents with obesity, a higher androsterone-to-etiocholanolone ratio was associated with insulin resistance, particularly in boys. The ratio reflects increased 5-alpha-reductase activity, which researchers interpret as a compensatory response your body makes when it has too much circulating cortisol or androgen activity. A meta-analysis of women with polycystic ovary syndrome (PCOS) found the same pattern: increased 5-alpha-reductase activity tied to insulin resistance, regardless of body weight.

What this means for you: if you have signs of PCOS (irregular periods, acne, excess hair growth) or insulin resistance, the androsterone-to-etiocholanolone ratio can help characterize the metabolic pattern driving your symptoms beyond what fasting insulin and testosterone alone show.

Other Conditions Linked to Altered Levels

• Congenital adrenal hyperplasia (21-hydroxylase deficiency): the androsterone-to-etiocholanolone ratio rises when an alternative steroid pathway (the backdoor pathway to DHT) becomes active, observed in a study of 280 people.
• Severe anorexia nervosa: the ratio is low during starvation and returns toward normal with refeeding, based on a 22-person study, indicating reversible changes in steroid processing.
• Autism spectrum: boys with Asperger and Kanner's syndrome showed higher urinary androsterone and etiocholanolone with distinctive correlation patterns versus controls, suggesting a broader steroid signature rather than a stand-alone abnormality.
• Thyroid disease: the balance between androsterone and etiocholanolone shifts in both myxedema (severe hypothyroidism) and hyperthyroidism, reflecting thyroid hormone's influence on how the liver processes androgens.

Reference Ranges

Etiocholanolone is a research-grade marker without standardized clinical cutpoints. Reference ranges vary widely between labs depending on whether the sample is serum or urine, whether the test measures the free form or the sulfate (etiocholanolone-S), and which assay method is used (mass spectrometry methods predominate). No major guideline body publishes recommended thresholds. Your lab will provide its own reference interval; treat it as an orientation point rather than a hard cutoff, and compare your results within the same lab over time for the most meaningful trend.

Why One Reading Is Not Enough

Steroid metabolites fluctuate based on circadian rhythm, recent food intake, stress, and where you are in your menstrual cycle if you menstruate. A single reading captures a moment, not your steady state. The more useful signal comes from tracking the trend, ideally with the same lab and the same assay method, alongside the androsterone-to-etiocholanolone ratio and any other steroid metabolites your panel includes.

A reasonable cadence: establish a baseline now, retest in 3 to 6 months if you are making targeted changes (treating insulin resistance, addressing PCOS, supporting bone health, treating fatty liver), and at least annually thereafter to watch for drift. Because this marker is genuinely exploratory, the best use of repeat testing is to confirm patterns rather than chase a single number toward a specific target.

When Results Can Be Misleading

Several factors can shift a single reading without reflecting a real change in your underlying biology:

• Time of day and recent meals: steroid metabolite levels rise and fall throughout the day. Standardize your draw time across tests.
• Menstrual cycle phase: if you menstruate, etiocholanolone and related metabolites vary across the cycle. Note your cycle day on each draw.
• Recent oral hormone use: oral testosterone and androstenedione both increase urinary etiocholanolone substantially, documented in studies used by anti-doping labs. If you are taking these, the result reflects the drug, not your baseline.
• Assay variation: different labs use different methods. Always compare your own results within the same lab.

What to Do With an Abnormal Result

Because this is a research-grade marker, a single abnormal value should not drive a clinical decision by itself. The next step is to look at the pattern in context. If your result is unusual alongside abnormal liver enzymes (ALT, AST, GGT) and signs of insulin resistance, consider a fatty liver workup. If it shifts alongside abnormal cortisol or DHEA-S, an endocrinologist can interpret the steroid panel as a whole. If you have signs of PCOS, pair this with fasting insulin, free testosterone, SHBG, and LH/FSH for a fuller picture. The marker earns its value when read with companions, not alone.